MX2016006006A - Metodo para el manejo del cancer y para el tratamiento de las comorbilidades relacionadas con el cancer. - Google Patents
Metodo para el manejo del cancer y para el tratamiento de las comorbilidades relacionadas con el cancer.Info
- Publication number
- MX2016006006A MX2016006006A MX2016006006A MX2016006006A MX2016006006A MX 2016006006 A MX2016006006 A MX 2016006006A MX 2016006006 A MX2016006006 A MX 2016006006A MX 2016006006 A MX2016006006 A MX 2016006006A MX 2016006006 A MX2016006006 A MX 2016006006A
- Authority
- MX
- Mexico
- Prior art keywords
- cancer
- extract
- species
- management
- treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 5
- 201000011510 cancer Diseases 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 241000234282 Allium Species 0.000 abstract 1
- 206010006895 Cachexia Diseases 0.000 abstract 1
- 241000207199 Citrus Species 0.000 abstract 1
- 208000010428 Muscle Weakness Diseases 0.000 abstract 1
- 206010028372 Muscular weakness Diseases 0.000 abstract 1
- 206010028813 Nausea Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 241001119526 Paullinia Species 0.000 abstract 1
- 241000219161 Theobroma Species 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 abstract 1
- 208000022531 anorexia Diseases 0.000 abstract 1
- 206010003549 asthenia Diseases 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 230000002601 intratumoral effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000008693 nausea Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 230000008673 vomiting Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un método para el manejo del cáncer y para el tratamiento de las comorbilidades del cáncer, incluyendo pero sin limitarse a la fatiga relacionada con el cáncer, caquexia, anorexia, dolor, anemia, astenia, depresión, debilidad muscular, nausea, vómito, lesiones adversas en la piel y en los apéndices de la piel; dicho método comprende la administración tanto por las vías convencionales como no convencionales: oral, tópica, parenteral, inyección intratumoral o una combinación de ellos, o la administración como potenciador adyuvante en otros tratamientos utilizando las vías mencionadas, de una composición que contenga como ingrediente activo un extracto de la especie AIIium, la cual contiene quercetina, un extracto de las especies Citrus y un extracto de la especie Paullinia y un extracto de la especie Theobroma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361901631P | 2013-11-08 | 2013-11-08 | |
PCT/EP2014/074048 WO2015067759A1 (en) | 2013-11-08 | 2014-11-07 | Method for the management of cancer and treatment of cancer comorbidities |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016006006A true MX2016006006A (es) | 2016-07-18 |
Family
ID=51868963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016006006A MX2016006006A (es) | 2013-11-08 | 2014-11-07 | Metodo para el manejo del cancer y para el tratamiento de las comorbilidades relacionadas con el cancer. |
Country Status (16)
Country | Link |
---|---|
US (2) | US10357531B2 (es) |
EP (1) | EP3065751B1 (es) |
JP (1) | JP6742904B2 (es) |
KR (1) | KR102344748B1 (es) |
CN (2) | CN105682671A (es) |
AU (1) | AU2014345539B2 (es) |
BR (1) | BR112016009931B1 (es) |
CA (1) | CA2928675C (es) |
DK (1) | DK3065751T3 (es) |
ES (1) | ES2777250T3 (es) |
HK (1) | HK1223844A1 (es) |
MX (1) | MX2016006006A (es) |
PL (1) | PL3065751T3 (es) |
PT (1) | PT3065751T (es) |
RU (1) | RU2016117205A (es) |
WO (1) | WO2015067759A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2862598A1 (en) | 2013-10-16 | 2015-04-22 | Legacy Healthcare Holding Ltd. | Use of a composition for the pigmentation of hair and hairs |
WO2017186954A1 (en) * | 2016-04-28 | 2017-11-02 | Legacy Healthcare Ltd | Method for the improvement of speed and endurance capacity |
CN113164440A (zh) * | 2018-11-30 | 2021-07-23 | 贝斯以色列女执事医疗中心有限公司 | 减少癌症患者的主要血栓事件的组合物和方法 |
FR3109881B1 (fr) * | 2020-05-07 | 2022-10-21 | Legacy Healthcare Switzerland Sa | Procede pour ameliorer le systeme immun pour acquerir la pan-immunite |
US11819530B1 (en) | 2023-05-17 | 2023-11-21 | Legacy Healthcare (Switzerland) Sa | Long term treatment of hair loss |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2844614A1 (de) | 1978-10-13 | 1980-05-08 | Alfred Czypull | Bio-aktiv-haartinktur |
JPH04342517A (ja) | 1990-07-20 | 1992-11-30 | Yutaka Miyauchi | 5α−リダクターゼ阻害剤 |
CH682217A5 (en) | 1991-05-23 | 1993-08-13 | Linda Singer Dolla | Hair lotion comprising aq. alcoholic extract of natural plant material - and aromatic plant substances and prepn., for treating or preventing baldness |
FR2706771A1 (en) | 1993-06-21 | 1994-12-30 | Pelletier Jacques | Formula for the treatment of certain cancers. |
JP3233813B2 (ja) | 1995-03-31 | 2001-12-04 | 株式会社マンダム | チロシナーゼ生合成促進剤及び白髪改善用又は白髪防止用頭髪用化粧料並びに日焼け用化粧料 |
DE19533777A1 (de) | 1995-09-12 | 1997-03-13 | Walther Aria Ellen | Haarwuchsmittel |
JP3527584B2 (ja) | 1996-01-23 | 2004-05-17 | 株式会社ナリス化粧品 | 養毛・育毛剤 |
US5773241A (en) | 1996-09-05 | 1998-06-30 | Ericsson; Arthur Dale | Preparation of bioactive extracts |
JP2000044439A (ja) | 1998-07-31 | 2000-02-15 | Shiseido Co Ltd | 頭皮頭髪用組成物 |
JP2000247830A (ja) | 1999-02-26 | 2000-09-12 | Nagase & Co Ltd | エラスターゼ阻害剤 |
EP1228769A1 (de) | 2001-02-02 | 2002-08-07 | Jörg-Peter Prof. Schür | Symbiontisches Regenerativum |
US6582702B2 (en) * | 2001-07-10 | 2003-06-24 | Alvin Foster Rigby | Herbal tonic composition that improves respiration, aids in the elimination of toxins and improves overall vitality |
US20030077336A1 (en) | 2001-10-10 | 2003-04-24 | Maf Group, Llc | Anti-inflammatory complex containing flaxseed oil |
JP2003201229A (ja) | 2001-10-23 | 2003-07-18 | Shiseido Co Ltd | マトリックスメタロプロテアーゼ活性阻害剤および抗老化用化粧料 |
US20030105104A1 (en) * | 2001-11-27 | 2003-06-05 | Burzynski Stanislaw R. | Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
BR0203591A (pt) * | 2002-09-05 | 2004-05-25 | Marc Kipfer | Bebida reidratante e energética natural a base de água-de-coco, sucos de frutas e componentes nutritivos incorporados |
DE102004011968A1 (de) | 2004-03-10 | 2005-09-29 | Henkel Kgaa | Präbiotisch wirksame Pflanzenextrakte |
KR20070022018A (ko) * | 2004-03-19 | 2007-02-23 | 네스텍소시에테아노님 | 기능성 재료의 전달 |
MY142017A (en) * | 2004-03-19 | 2010-08-16 | Nestec Sa | Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same |
US20060018867A1 (en) | 2004-05-12 | 2006-01-26 | Ichimaru Pharcos Co., Ltd | Cosmetic composition and production thereof |
WO2005120452A1 (en) | 2004-06-07 | 2005-12-22 | Katica Pavlovic | A procedure in production of a curative creams for regeneration of skin tissue, easer breathing, psoriasis, pains and tiredness in legs |
FR2865132A1 (fr) | 2004-07-06 | 2005-07-22 | Oreal | Utilisation de la diosmetine, d'un de ses derives ou d'un extrait de plante contenant l'un d'eux pour favoriser la pigmentation de la peau et/ou des cheveux |
DE202004012348U1 (de) | 2004-08-03 | 2004-10-07 | Jabal Amman, Suhbi Hasan Mohammes | Zubereitung zur Pflege der Haut bei Psoriasis oder Ekzem |
US7462595B2 (en) * | 2004-09-17 | 2008-12-09 | Prange Jr Arthur Jergen | Methods for treating cancer-related fatigue |
JP2006104098A (ja) | 2004-10-04 | 2006-04-20 | Ichimaru Pharcos Co Ltd | ヒアルロニダーゼ活性阻害剤 |
FR2877219B1 (fr) | 2004-10-28 | 2007-03-09 | Fatima Basri | Composition utilisee en cosmetique ou en pharmacologie pour stimuler la synthese du collagene |
FR2877576B1 (fr) | 2004-11-08 | 2007-03-09 | Ahmed Kadri | Composition pharmaceutique utilisee pour stimuler la proliferation et l'activation des mastocytes |
DE102005010142A1 (de) | 2005-03-02 | 2005-11-03 | Dr. Kurt Wolff Gmbh & Co. Kg | Mittel zur Aktivierung der Haarwurzeln und Verwendung des Mittels |
JP4804805B2 (ja) | 2005-06-10 | 2011-11-02 | 横関油脂工業株式会社 | 細胞賦活剤、紫外線障害緩和剤及びメラニン産生抑制剤 |
WO2008015341A2 (fr) | 2006-08-03 | 2008-02-07 | Societe D'extraction Des Principes Actifs Sa (Vincience) | Utilisation d'un extrait vegetal en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes |
FR2912310B1 (fr) * | 2007-02-13 | 2009-08-07 | Kasan Sarl | Nouvelles compositions cosmetiques et/ou pharmaceutiques et leurs applications. |
US8088431B2 (en) * | 2007-03-14 | 2012-01-03 | The Hershey Company | Health bars and compositions for improving mental and physical energy |
US20080305096A1 (en) | 2007-06-07 | 2008-12-11 | Unicity International, Inc. | Method and composition for providing controlled delivery of biologically active substances |
FR2939646B1 (fr) | 2008-12-12 | 2017-04-14 | Oreal | Procede de coloration capillaire a partir d'une composition comprenant au moins un orthodiphenol, un sel metallique, du peroxyde d'hydrogene, du (bi)carbonate et un agent alcalinisant |
KR102021075B1 (ko) * | 2009-06-22 | 2019-11-04 | 에스케이바이오팜 주식회사 | 피로의 치료 또는 예방 방법 |
WO2011005311A1 (en) * | 2009-07-07 | 2011-01-13 | Robert Shorr | Pharmaceutical composition |
WO2012017361A2 (en) | 2010-08-05 | 2012-02-09 | Legacy Healthcare Holding Ltd | Method for stimulating hair growth |
EP2678023A1 (en) | 2011-02-23 | 2014-01-01 | Legacy Healthcare Ltd | New use of compositions for preventing chemotherapy and radiotherapy induced alopecia (cria), reducing cria impact and improving the appearance of hair re-growth after cria |
WO2012140013A2 (en) | 2011-04-11 | 2012-10-18 | Legacy Healthcare Holding Ltd | New use of compositions for the treatment of inflammatory skin conditions, scaly scalp conditions and collagen remodeling. |
WO2013020719A2 (en) * | 2011-08-09 | 2013-02-14 | Legacy Healthcare Holding Ltd | New use of compositions to delay the onset of the catagen phase of the hair |
EP2862598A1 (en) | 2013-10-16 | 2015-04-22 | Legacy Healthcare Holding Ltd. | Use of a composition for the pigmentation of hair and hairs |
-
2014
- 2014-11-07 BR BR112016009931-1A patent/BR112016009931B1/pt active IP Right Grant
- 2014-11-07 WO PCT/EP2014/074048 patent/WO2015067759A1/en active Application Filing
- 2014-11-07 PL PL14795825T patent/PL3065751T3/pl unknown
- 2014-11-07 AU AU2014345539A patent/AU2014345539B2/en active Active
- 2014-11-07 PT PT147958250T patent/PT3065751T/pt unknown
- 2014-11-07 CA CA2928675A patent/CA2928675C/en active Active
- 2014-11-07 CN CN201480060350.5A patent/CN105682671A/zh active Pending
- 2014-11-07 DK DK14795825.0T patent/DK3065751T3/da active
- 2014-11-07 MX MX2016006006A patent/MX2016006006A/es unknown
- 2014-11-07 RU RU2016117205A patent/RU2016117205A/ru not_active Application Discontinuation
- 2014-11-07 US US15/032,179 patent/US10357531B2/en active Active
- 2014-11-07 ES ES14795825T patent/ES2777250T3/es active Active
- 2014-11-07 CN CN202211114854.3A patent/CN115350236A/zh active Pending
- 2014-11-07 EP EP14795825.0A patent/EP3065751B1/en active Active
- 2014-11-07 JP JP2016528184A patent/JP6742904B2/ja active Active
- 2014-11-07 KR KR1020167013957A patent/KR102344748B1/ko active IP Right Grant
-
2016
- 2016-10-25 HK HK16112239.8A patent/HK1223844A1/zh unknown
-
2019
- 2019-06-26 US US16/453,379 patent/US20190314441A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP3065751B1 (en) | 2019-12-18 |
PL3065751T3 (pl) | 2020-07-13 |
CA2928675C (en) | 2023-09-05 |
KR20160074006A (ko) | 2016-06-27 |
ES2777250T3 (es) | 2020-08-04 |
HK1223844A1 (zh) | 2017-08-11 |
KR102344748B1 (ko) | 2021-12-30 |
BR112016009931B1 (pt) | 2021-02-02 |
AU2014345539A8 (en) | 2016-05-26 |
PT3065751T (pt) | 2020-03-06 |
RU2016117205A (ru) | 2017-12-11 |
DK3065751T3 (da) | 2020-03-09 |
RU2016117205A3 (es) | 2018-08-09 |
AU2014345539A1 (en) | 2016-05-19 |
US20160256512A1 (en) | 2016-09-08 |
JP2016535753A (ja) | 2016-11-17 |
CA2928675A1 (en) | 2015-05-14 |
EP3065751A1 (en) | 2016-09-14 |
WO2015067759A1 (en) | 2015-05-14 |
US20190314441A1 (en) | 2019-10-17 |
US10357531B2 (en) | 2019-07-23 |
CN105682671A (zh) | 2016-06-15 |
JP6742904B2 (ja) | 2020-08-19 |
CN115350236A (zh) | 2022-11-18 |
AU2014345539B2 (en) | 2020-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021015234A (es) | Composiciones y metodos que comprenden bupropion o compuestos relacionados y dextrometorfano. | |
MX2016006006A (es) | Metodo para el manejo del cancer y para el tratamiento de las comorbilidades relacionadas con el cancer. | |
JO3522B1 (ar) | تركيب صيدلاني يتألف من كريات حمراء تغلف إنزيم يعتمد على بيريدكسال الفوسفات والعامل المساعد له | |
MX2015009106A (es) | Composiciones de solución sólida y su uso en el tratamiento del dolor intenso. | |
HRP20191265T8 (hr) | Supstituirani 2-tiokso-imidazolidin-4-oni i njihovi spiro analozi, aktivni anti-kancerogeni sastojak, farmaceutska kompozicija, medicinski preparat, metoda za liječenje raka prostate | |
MX2019008999A (es) | Composicion inyectable para prevenir la perdida del pelo o estimular el crecimiento del pelo. | |
SA113340494B1 (ar) | تركيبة لعلاج اضطرابات أيضية | |
EP3199171A4 (en) | Pharmaceutical composition for treating and preventing degenerative neurological disorders, containing, as active ingredient, mixture extract of moutan root bark, angelica dahurica root and bupleurum root or fraction thereof | |
PL3031465T3 (pl) | Kompozycja farmaceutyczna do sprzyjania tworzeniu tkanki kostnej, zawierająca jako składnik czynny wyciąg z liści stauntonia hexaphylla | |
MX2015000179A (es) | Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas. | |
MX2018014129A (es) | Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato. | |
MX2020001428A (es) | Composiciones de grapiprant y metodos para usar las mismas. | |
GB2498677A (en) | Extracts of cynanchum SP.and active ingredients contained therein in use of arthritis treatment | |
EP3146976A4 (en) | Pharmaceutical composition for preventing or treating diabetic complications and angioedema, containing natural mixture extract as active ingredient | |
WO2018062876A3 (ko) | 통증이 경감되는 골관절염 치료용 키트 | |
MX359887B (es) | Composicion masticable para administracion oral y proceso para preparar la misma. | |
WO2015027121A3 (en) | Cancer treatment | |
NZ630125A (en) | Herbal composition for the treatment of metabolic disorders | |
WO2012108747A3 (ko) | 토목향 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물 | |
IN2013MU03428A (es) | ||
WO2012108743A3 (ko) | 백축 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물 | |
EP3417867A4 (en) | COMPOSITION WITH MEDICINAL EXTRACT AS ACTIVE AGENT FOR PREVENTING, DISABLING, OR TREATING STRESS OR DEPRESSIONS | |
UA96112C2 (ru) | Фармацевтическая композиция, стимулирующая биосинтез s-аденозилметионина, и пероральное лекарственное средство | |
UA87822U (ru) | Фармакологическое композиция для лечения постимплантационных осложнений | |
WO2012134165A3 (ko) | 보골지 추출물을 포함하는 폐암 치료용 조성물 및 화장료 조성물 |